Close Menu

IVDMIA

One group pointed out differences between study group characteristics, while the other wondered about the role of patient preference.

The firm believes the diagnostics industry has not done a good job of communicating the value of medical tests to payors.

Members of a US House of Representatives subcommittee have called on the US Food and Drug Administration to respond to "significant concern" regarding the agency's draft guidance document on research-use-only and investigational-use-only diagnostic products.

NEW YORK (GenomeWeb News) – Agendia today said that it has signed a contract with Blue Shield of California, making it an in-network provider.

After receiving stakeholder input at a meeting last month on potential coding structures that would facilitate accurate payment for in vitro diagnostic multivariate index assays, an expert panel advising the American Medical Association said it has not yet decided on the

CMS is looking to hire expert personnel who can provide clinical support as it updates its clinical laboratory fee schedule for new and existing tests and analyzes new codes for molecular pathology tests.

The additional clearance will expand laboratory capacity to handle the increasing number of MammaPrint, TargetPrint, and BluePrint test results.

The company plans to use proceeds from the public offering Vermillion to expand into international markets, fund clinical trials for its peripheral artery disease test, "pursue opportunities to diversity our product and service lines and offerings," and general corporate purposes.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.